Seaport Therapeutics Inc SPTX

US Pharmaceuticals

$21.52 ▲ +1.89% (+$0.40)

⬆️ Above Yest. High

Open $22.20

Prev Close $21.12

Day Range $21.45 – $22.44

52W Range $14.85 – $28.38

Market Cap $1.15B

Beta 0.46

EPS (TTM) $-1.65

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2026-05-01
Shares Out.	53,530,000
Website	seaporttx.com ↗
Phone	13026587581
Revenue	$0
Gross Profit	$0
Net Income	-$62.6M
Total Assets	$441.7M
Total Liabilities	$19.1M
Equity	$422.6M

About Seaport Therapeutics Inc

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Seaport Therapeutics Inc is a publicly traded company under the ticker symbol SPTX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.